Supply and Demand-Side Interventions to Improve Uptake of Antenatal Care Services: a Randomized Controlled Trial in Rural Côte d’Ivoire

Last registered on January 12, 2026

Pre-Trial

Trial Information

General Information

Title
Supply and Demand-Side Interventions to Improve Uptake of Antenatal Care Services: a Randomized Controlled Trial in Rural Côte d’Ivoire
RCT ID
AEARCTR-0017633
Initial registration date
January 12, 2026

Initial registration date is when the trial was registered.

It corresponds to when the registration was submitted to the Registry to be reviewed for publication.

First published
January 12, 2026, 8:26 AM EST

First published corresponds to when the trial was first made public on the Registry after being reviewed.

Locations

There is information in this trial unavailable to the public. Use the button below to request access.

Request Information

Primary Investigator

Affiliation
Swiss Tropical and Public Health Institute

Other Primary Investigator(s)

PI Affiliation
Swiss Tropical and Public Health Institute

Additional Trial Information

Status
In development
Start date
2026-01-14
End date
2027-12-31
Secondary IDs
Prior work
This trial does not extend or rely on any prior RCTs.
Abstract
The past two decades have brought significant increases in the availability of maternal health care services in many low- and middle-income countries, with a large increase in the number of health facilities that provide these services. However, many women still do not receive the basic services recommended by the World Health Organization. In many settings, antenatal care is associated with substantial financial cost, which means that obtaining high quality care can involve complex intra-household bargaining and decision-making. Women have more access to information about these services, but men generally make the financial decisions. If men are unaware of the magnitude and timing of financial needs, securing adequate financial resources may be difficult.
We will conduct a randomized-controlled experiment of supply- and demand-side solutions to increase uptake of recommended antenatal care services in rural Côte d’Ivoire, where there are currently substantial gaps in service coverage. Despite Côte d’Ivoire’s “free maternity care” policy, many recommended services – including ultrasounds and laboratory tests – continue to carry costs for patients. On the supply side, the study will evaluate the impact of providing key services (including ultrasounds, laboratory testing, and iron and folic acid supplements) for free to pregnant women (in line with Côte d’Ivoire’s policy of free provision). On the demand side, the study will evaluate the impact of providing information about antenatal care recommendations to pregnant women (alone or with their partners), and of providing a financial planning session to pregnant women or their partners, or both together. The study will evaluate the impacts of these interventions on the uptake of recommended antenatal care services.
External Link(s)

Registration Citation

Citation
Clarke-Deelder, Emma and Günther Fink. 2026. "Supply and Demand-Side Interventions to Improve Uptake of Antenatal Care Services: a Randomized Controlled Trial in Rural Côte d’Ivoire." AEA RCT Registry. January 12. https://doi.org/10.1257/rct.17633-1.0
Sponsors & Partners

There is information in this trial unavailable to the public. Use the button below to request access.

Request Information
Experimental Details

Interventions

Intervention(s)
This study involves three interventions:
1) Information video – In this video, participants will be shown a short video that describes key recommendations for antenatal care and health during pregnancy, based on national guidelines in Cote d’Ivoire. In intervention groups (1) and (2), this video will be shown only to the pregnant woman. In intervention group (3), this video will be shown to the pregnant woman together with her partner.
2) Financial planning session – In this intervention, a member of the study team will facilitate a structured discussion about planning for the expenses of health care services and related transportation costs over the course of pregnancy. The discussion will follow a series of questions and prompts set up as a survey form in ODK (attached to this protocol). The study team member will also share a list of the local prices of recommended antenatal care services. In intervention group (2), this intervention is delivered only to pregnant women. In intervention group (3), this intervention is delivered to pregnant women together with their partners.
3) Vouchers for antenatal care services – This intervention consists of vouchers for a pre-defined set of antenatal care services. Pregnant women who are randomized to receive this intervention will be given vouchers for one ultrasound, one “bilan prenatal” (a recommended set of prenatal laboratory tests in Cote d’Ivoire), and a 6-month supply of iron & folic acid supplements (with dosage based on her health care provider’s recommendation). The study team will establish agreements with local health facilities to provide services in exchange for these vouchers, with reimbursement by the study team.

Intervention Start Date
2026-01-14
Intervention End Date
2026-09-30

Primary Outcomes

Primary Outcomes (end points)
Proportion of women receiving recommended antenatal care services
Primary Outcomes (explanation)
The primary endpoint is the portion of women receiving the following recommended antenatal care services during their pregnancy, as measured through recall during endline surveys with pregnant women:
• At least four antenatal care visits with a skilled provider AND
• At least one ultrasound AND
• At least one laboratory assessment.

Secondary Outcomes

Secondary Outcomes (end points)
1. Proportion of participants receiving the recommended number of malaria chemoprophylaxis doses during pregnancy
2. Proportion of participants receiving high-quality antenatal care measured using antenatal care booklets
3. Average antenatal care knowledge scores among pregnant women and their partners
4. Portion of women who delayed or missed care for financial reasons
5. Proortion of women who are satisfied with the antenatal care health services that they received
Portion of women responding “Excellent” or “Very good” to the question, “How would you rate the overall quality of care you received during your most recent pregnancy? Excellent, Very good, Good, Fair, Poor.”
6. Proportion of fathers involved in early care-giving activities
7. Perinatal mortality as reported by women during endline surveys
8. Birthweight as reported by women during endline surveys
Secondary Outcomes (explanation)
1. Portion of participants who receive at least three doses of malaria chemoprophylaxis during pregnancy as reported by study participants during endline interviews
[Time Frame: During pregnancy (measured 4-8 weeks after the end of pregnancy)]
2. High-quality antenatal care (defined as at least 4 antenatal care visits with a skilled provider, at least one ultrasound, and at least one laboratory assessment) as measured through review of antenatal care booklets (as opposed to measurement by maternal recall). This secondary endpoint will only be measured in cases when women have an ANC book available at the time of the endline interview.
[Time Frame: During pregnancy (measured 4-8 weeks after the end of pregnancy)]
3. Average scores (among pregnant women and among their partners) on assessments of knowledge of antenatal care recommendations, as measured using the following questions during endline surveys with pregnant women and their partners:
1. During antenatal care visits, health care providers conduct some examinations and tests. Can you tell me which examinations and tests they should conduct?
2. During antenatal care visits, health care providers also sometimes give medications or treatments. Can you tell me which medications they should provide to all pregnant women?

Participants receive 1 point for each correct test or examination they mention in response to Q1 and 1 point for each correct medication or treatment they mention in response to Q2.
[Time Frame: Measured 4-8 weeks after the end of pregnancy]
4. Proportion of women who respond “yes” to one or both of the following questions during endline surveys:
• During your most recent pregnancy, did you ever delay your visit to the hospital because of financial issues?
• During your most recent pregnancy, did you ever skip recommended care - like an ultrasound or a blood test - because of money problems?
[Time Frame: Measured 4-8 weeks after the end of pregnancy]
5. Proportion of women responding “Excellent” or “Very good” to the question, “How would you rate the overall quality of care you received during your most recent pregnancy? Excellent, Very good, Good, Fair, Poor.”
[Time Frame: Measured 4-8 weeks after the end of pregnancy]
6. Proportion of mothers who respond “everyday” or “most days” to the following question during endline surveys: “How often does the father of the child participate in daily care activities such as feeding, bathing, or changing diapers? Every day, most days, some days, or never.”
[Time Frame: Measured 4-8 weeks after the end of pregnancy]
7. Mortality between 28 weeks of pregnancy and 7 days after birth, as reported by women during endline surveys
[Time Frame: Measured 4-8 weeks after the end of pregnancy]
8. Birthweight in grams, as reported by women during endline surveys

Experimental Design

Experimental Design
Women will be randomized to one of the three study groups: In group 1, the information video will only be shown to the pregnant women, not to their partners. In group 2, the information video AND the financial planning intervention will only be given to pregnant women, not to their partners. In group 3, the information video will be shown to the pregnant woman and her partner, and the financial planning session will be done with both partners together. Within these three intervention groups, each woman will be randomized to intervention version (a) with no vouchers for antenatal care services or version (b) with vouchers for antenatal care services. Randomization to vouchers (or no vouchers) will be done after the information video and financial planning interventions are completed. The vouchers will be explained directly to the pregnant woman.
Experimental Design Details
Not available
Randomization Method
Random number draw on tablet (ODK).
Randomization Unit
Woman (individual level).
Was the treatment clustered?
No

Experiment Characteristics

Sample size: planned number of clusters
NA
Sample size: planned number of observations
1290
Sample size (or number of clusters) by treatment arms
We anticipate enrolling 1290 pregnant women.
Minimum detectable effect size for main outcomes (accounting for sample design and clustering)
Enrolling 430 women in each intervention arm provides 81% power to detect a 10 percentage point change in antenatal service coverage (from 36% to 46%) assuming 90% follow-up, comparing each intervention arm to the control arm and comparing the two intervention arms to each other. We anticipate cross-randomizing the voucher intervention so that 43 women in each study arm receive vouchers. Assuming 10% attrition, we will have 87% power to detect a 15 percentage point change in antenatal care service coverage (from 36% to 51%) comparing the vouchers recipients to non-vouchers recipients.
IRB

Institutional Review Boards (IRBs)

IRB Name
Ethikkommission Nordwest- und Zentralschweiz
IRB Approval Date
2025-12-02
IRB Approval Number
AO 2025-00 l 06
IRB Name
Comité National d’Éthique des Sciences de la Vie et de la Santé
IRB Approval Date
2025-12-05
IRB Approval Number
00250